neovascular glaucoma | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,117 results for “neovascular glaucoma”

New Genetic Findings Challenge Traditional Understanding of Coats' Disease

FDA Grants Orphan Drug and Rare Pediatric Disease Designations to ATSN-201 for X-Linked Retinoschisis

Faricimab Demonstrates Efficacy in Treatment-Naïve Neovascular AMD Patients

ABBV-RGX-314 Gene Therapy Shows Promise in Bilateral Neovascular AMD

Real-World Study Confirms High-Volume Intravitreal Injections Do Not Increase Glaucoma Risk

OCT Biomarkers Distinguish Progression to Neovascular vs. Atrophic AMD in Intermediate Disease

Study on Adherence to Glaucoma Medication Regimens

Kalaris Therapeutics Secures $50 Million Funding to Advance TH103 for Neovascular AMD Treatment

Positive Phase 3 Data and New Glaucoma Treatments Highlight Advancements in Ophthalmology

Innovent's Efdamrofusp Alfa Shows Promising Results for Neovascular AMD with Extended Dosing Potential

Page 1 of 38